NT PHARMA: CHANGE OF ADDRESS OF THE PRINCIPAL PLACE OF BUSINESS AND HEADQUARTERS
NT PHARMA: PROPOSED SHARE CONSOLIDATION AND CHANGE IN BOARD LOT SIZE
NT PHARMA: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024
NT PHARMA: Notification Letter and Request Form to Non-Registered Holder
NT PHARMA: Notification Letter and Request Form to Registered Shareholder
NT PHARMA: FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING
NT PHARMA: NOTICE OF ANNUAL GENERAL MEETING
NT PHARMA: PROPOSED GRANTING OF GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES, PROPOSED RE-ELECTION OF RETIRING DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING
NT PHARMA: Annual Report 2023
NT PHARMA: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
NT PHARMA: ANNOUNCEMENT OF AUDITED ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023
NT PHARMA: DATE OF BOARD MEETING
NT PHARMA: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024
NT PHARMA: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024
NT PHARMA: LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
NT PHARMA: SUPPLEMENTAL ANNOUNCEMENT IN REALTED TO (1) REDESIGNATION OF DIRECTOR AND (2) APPOINTMENT OF EXECUTIVE DIRECTOR
NT PHARMA: (1) REDESIGNATION OF DIRECTOR AND (2) APPOINTMENT OF EXECUTIVE DIRECTOR
NT PHARMA: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023
NT PHARMA: CHANGES OF (1) COMPANY SECRETARY, (2) AUTHORISED REPRESENTATIVE AND (3) AGENT FOR THE ACCEPTANCE OF SERVICE OF PROCESS AND NOTICES IN HONG KONG
NT PHARMA: Monthly Return of Equity Issuer on Movements in Securities For the month ended 30 November 2023
No Data